Nephros, Inc. (NASDAQ:NEPH) Q3 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Nephros Inc. Third Quarter 2024 Financial Results Conference Call. All participants will be in listen-only mode.
Nephros Inc (NEPH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Wexford Capital Charles Davidson | 3,608,081 | $14,757,054 | +1% | 4.12% |
| 2. | Topline Capital Collin Mcbirney | 477,449 | $1,952,766 | +14% | 0.33% |
| 3. | Elkhorn Partners Alan S. Parsow | 14,500 | $59,305 | -63% | 0.04% |
| 4. | Citadel Investment Group Ken Griffin | 11,890 | $48,630 | -2% | 0% |
| 5. | Renaissance Technologies Jim Simons | 10,900 | $44,581 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.24 | 3,000 | $6,734.70 | 103,463 | 2024-05-30 | Filing | |
| $2.22 | 2,000 | $4,441.40 | 100,463 | 2024-05-28 | Filing | |
| $2.24 | 50,000 | $112,050.00 | 70,000 | 2024-05-16 | Filing | |
| $2.45 | 7,000 | $17,129.70 | 7,000 | 2024-03-12 | Filing | |
| $2.20 | 18,000 | $39,646.80 | 20,000 | 2023-12-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.95 | 200,000 | $389,180.00 | 96,730 | 2009-09-02 | Filing | |
| $1.95 | 92,000 | $179,022.80 | 296,730 | 2009-09-01 | Filing | |
| $1.86 | 101,000 | $187,466.10 | 388,730 | 2009-08-31 | Filing | |
| $1.97 | 200,000 | $393,900.00 | 489,730 | 2009-08-28 | Filing | |
| $2.02 | 200,000 | $403,240.00 | 689,730 | 2009-08-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 323,443 | $1,322,882 | 0% | |
| 2. | 131,121 | $536,285 | 0.17% | |
| 3. | 93,187 | $381,211 | 0% | |
| 4. | 55,876 | $228,533 | 0% | |
| 5. | 36,249 | $148,258 | 0% |
News See All
Nephros, Inc. (NASDAQ:NEPH) Q2 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Nephros Inc. Second Quarter 2024 Financial Results Conference Call. [Operator Instructions] Please note, today’s event is being recorded.
Nephros, Inc. (NASDAQ:NEPH) Q4 2023 Earnings Call Transcript
Nephros, Inc. misses on earnings expectations. Reported EPS is $-37.91161 EPS, expectations were $-0.02.
Nephros, Inc. (NASDAQ:NEPH) Q3 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to the Nephros Inc. Third Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.
Nephros, Inc. (NASDAQ:NEPH) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, everyone, and welcome to the Nephros Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.
Nephros, Inc. (NASDAQ:NEPH) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, everyone, and welcome to the Nephros Incorporated. First Quarter 2023 Financial Results Conference Call.
Nephros, Inc. (NASDAQ:NEPH) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Nephros Inc. Fourth Quarter 2022 Financial Results Conference Call. Please note, this event is being recorded.
Where Do Hedge Funds Stand On Nephros, Inc. (NEPH)?
The Insider Monkey team has completed processing the quarterly 13F filings for the March quarter submitted by the hedge funds and other money managers included in our extensive database.
Where Do Hedge Funds Stand On Nephros, Inc. (NEPH)?
In this article we will check out the progression of hedge fund sentiment towards Nephros, Inc. (NASDAQ:NEPH) and determine whether it is a good investment right now.
Hedge Funds Getting Bullish On Nephros, Inc. (NEPH)
In this article you are going to find out whether hedge funds think Nephros, Inc. (NASDAQ:NEPH) is a good investment right now.
Billionaire Hedge Funds
